ABIGO PHARMA A/S: Financial statements 2018
CVR: 12927983
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
ABIGO PHARMA A/S (CVR 12927983) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 5,740,396 and a net result of DKK -240,139 compared with DKK 138,378 the year before. That is an increase of 7.8% compared with the year before. Equity in the 2018 report amounted to DKK -168,111. The company had 8 employees in the financial year.
- Gross Profit
- DKK 5,740,396
- Profit/Loss
- DKK -240,139
- Equity
- DKK -168,111
- Total Assets
- DKK 5,670,254
- Employees
- 8
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 5.7 mio. | -240 t. | -168 t. | 8 |
| 2017 | - | 5.3 mio. | 138 t. | -203 t. | - |
| 2016 | - | 5.8 mio. | 642 t. | -341 t. | - |
| 2015 | - | 3.5 mio. | 778 | -983 t. | - |
| 2014 | - | 2.8 mio. | 91 t. | -984 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of December 31, 2018, Bjarne Dennis Reffeldt Otte has left the board of directors of ABIGO PHARMA A/S.
ABIGO PHARMA A/S has published its interim report for the period May 1, 2017 – December 31, 2017.
As of April 3, 2018, Frank Åke Joakim Jehlbo has joined the board of directors of ABIGO PHARMA A/S.
As of April 3, 2018, Frank Åke Joakim Jehlbo is registered as adm. dir. of ABIGO PHARMA A/S.
As of April 3, 2018, Bjarne Dennis Reffeldt Otte has stepped down as adm. dir. of ABIGO PHARMA A/S.
About ABIGO PHARMA A/S
ABIGO PHARMA A/S was a Danish company of the type Aktieselskab based in Allerød, founded in 1989. The company has been dissolved on 27 June 2024. The company was registered under the industry Specialiseret engroshandel med fødevarer i.a.n.. The company was previously named DHC A/S and DANSK HELSEMIDDEL CENTER A/S. The company has 1 employee (2023). In 2023, the company reported revenue of DKK 9,189,036 and a net result of DKK 201,721 compared with DKK 165,903 the year before. Equity in the 2023 report amounted to DKK 4,838,794.